Literature DB >> 500202

Behavior of vaccine revertants of temperature-sensitive mutants of influenza virus in ferret tracheal organ culture.

S R Mostow, J A Hopkins, P F Wright.   

Abstract

A live attenuated influenza vaccine candidate was not genetically stable when administered to some children who lacked antibody to surface proteins of the virus. To obtain additional biological information about these revertants, the vaccine strain, the wild-type parental strain, and isolates recovered from inoculated children during a vaccine trial were evaluated in ferret tracheal organ culture for effects on the ciliated epithelium and replication at both permissive and restrictive temperatures. The studies revealed that the vaccine strain destroyed cilia and replicated to high titer at its permissive temperature (33 degrees ) but caused minimal damage and replicated to very low titer at its restrictive temperature (37 degrees C). The wild-type parent destroyed cilia at both 33 and 37 degrees C. Isolates which were no longer temperature sensitive (ts(+)) destroyed cilia at both restrictive and permissive temperatures and grew to high titer. Isolates which retained the ts phenotype behaved as the vaccine strain in this system. The ts(+) virus recovered from volunteers behaved like the wild-type parent, which suggests that these viruses had not merely lost their ts phenotype, but had undergone reversion to wild type. Important information about the genetic stability of temperature-sensitive influenza vaccine strains recovered from volunteers can be obtained by evaluating them in ferret tracheal organ culture.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500202      PMCID: PMC414594          DOI: 10.1128/iai.26.1.193-196.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Temperature-sensitive mutants of influenza virus. XIII. Evaluation of influenza A/Hong Kong/68 and A/Udorn/72 ts and wild-type viruses in tracheal organ culture at permissive and restrictive temperatures.

Authors:  S R Mostow; S Flatauer; M Paler; B R Murphy
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children.

Authors:  B R Murphy; D D Richman; S B Spring; R M Chanock
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

3.  Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; R M Chanock
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

4.  Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2).

Authors:  P F Wright; S H Sell; T Shinozaki; J Thompson; D T Karzon
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

5.  Temperature-sensitive mutants of influenza A virus: response of children to the influenza A/Hong Kong/68-ts-1(E) (H3N2) and influenza A/Udorn/72-ts-1(E) (H3N2) candidate vaccine viruses and significance of immunity to neuraminidase antigen.

Authors:  H W Kim; J O Arrobio; C D Brandt; R H Parrott; B R Murphy; D D Richman; R M Chanock
Journal:  Pediatr Res       Date:  1976-04       Impact factor: 3.756

6.  Live attenuated influenza vaccines in young seronegative children.

Authors:  P F Wright; M Kervina; J Thompson; A E Torrence; D T Karzon
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

7.  The behaviour in vitro of attenuated recombinant influenza viruses.

Authors:  S R Mostow; D A Tyrrell
Journal:  Arch Gesamte Virusforsch       Date:  1973
  7 in total
  3 in total

Review 1.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

2.  Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.

Authors:  Bin Zhou; Victoria A Meliopoulos; Wei Wang; Xudong Lin; Karla M Stucker; Rebecca A Halpin; Timothy B Stockwell; Stacey Schultz-Cherry; David E Wentworth
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

3.  Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene.

Authors:  Attapon Kamlangdee; Brock Kingstad-Bakke; Tavis K Anderson; Tony L Goldberg; Jorge E Osorio
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.